Skip to content

Clinical trials

Phase 3 Dyskinesias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyskinesias Phase: Phase 3 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20043
20051
20081
20094
20147
20152
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adamas Pharmaceuticals, Inc.5
AbbVie (prior sponsor, Abbott)4
Auspex Pharmaceuticals, Inc.2
Biotie Therapies Inc.2
EMD Serono2
GlaxoSmithKline2
US Department of Veterans Affairs2
AbbVie1
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals1
Neurocrine Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyskinesias24
Parkinson Disease19
Parkinsonian Disorders5
Central Nervous System Diseases2
Movement Disorders2
Nervous System Diseases2
Neurologic Manifestations2
Signs and Symptoms2
Tardive Dyskinesia2
Tremor2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.